711 related articles for article (PubMed ID: 21873190)
1. Ten-Eleven-Translocation 2 (TET2) negatively regulates homeostasis and differentiation of hematopoietic stem cells in mice.
Ko M; Bandukwala HS; An J; Lamperti ED; Thompson EC; Hastie R; Tsangaratou A; Rajewsky K; Koralov SB; Rao A
Proc Natl Acad Sci U S A; 2011 Aug; 108(35):14566-71. PubMed ID: 21873190
[TBL] [Abstract][Full Text] [Related]
2. TET2 is essential for survival and hematopoietic stem cell homeostasis.
Shide K; Kameda T; Shimoda H; Yamaji T; Abe H; Kamiunten A; Sekine M; Hidaka T; Katayose K; Kubuki Y; Yamamoto S; Miike T; Iwakiri H; Hasuike S; Nagata K; Marutsuka K; Iwama A; Matsuda T; Kitanaka A; Shimoda K
Leukemia; 2012 Oct; 26(10):2216-23. PubMed ID: 22469782
[TBL] [Abstract][Full Text] [Related]
3. Non-catalytic Roles of Tet2 Are Essential to Regulate Hematopoietic Stem and Progenitor Cell Homeostasis.
Ito K; Lee J; Chrysanthou S; Zhao Y; Josephs K; Sato H; Teruya-Feldstein J; Zheng D; Dawlaty MM; Ito K
Cell Rep; 2019 Sep; 28(10):2480-2490.e4. PubMed ID: 31484061
[TBL] [Abstract][Full Text] [Related]
4. Tet2 disruption leads to enhanced self-renewal and altered differentiation of fetal liver hematopoietic stem cells.
Kunimoto H; Fukuchi Y; Sakurai M; Sadahira K; Ikeda Y; Okamoto S; Nakajima H
Sci Rep; 2012; 2():273. PubMed ID: 22355785
[TBL] [Abstract][Full Text] [Related]
5.
Kunimoto H; McKenney AS; Meydan C; Shank K; Nazir A; Rapaport F; Durham B; Garrett-Bakelman FE; Pronier E; Shih AH; Melnick A; Chaudhuri J; Levine RL
Blood; 2017 Mar; 129(13):1779-1790. PubMed ID: 28077417
[TBL] [Abstract][Full Text] [Related]
6. TET2 as an epigenetic master regulator for normal and malignant hematopoiesis.
Nakajima H; Kunimoto H
Cancer Sci; 2014 Sep; 105(9):1093-9. PubMed ID: 25040794
[TBL] [Abstract][Full Text] [Related]
7. Deletion of Tet2 in mice leads to dysregulated hematopoietic stem cells and subsequent development of myeloid malignancies.
Li Z; Cai X; Cai CL; Wang J; Zhang W; Petersen BE; Yang FC; Xu M
Blood; 2011 Oct; 118(17):4509-18. PubMed ID: 21803851
[TBL] [Abstract][Full Text] [Related]
8. Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation.
Moran-Crusio K; Reavie L; Shih A; Abdel-Wahab O; Ndiaye-Lobry D; Lobry C; Figueroa ME; Vasanthakumar A; Patel J; Zhao X; Perna F; Pandey S; Madzo J; Song C; Dai Q; He C; Ibrahim S; Beran M; Zavadil J; Nimer SD; Melnick A; Godley LA; Aifantis I; Levine RL
Cancer Cell; 2011 Jul; 20(1):11-24. PubMed ID: 21723200
[TBL] [Abstract][Full Text] [Related]
9. Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2.
Ko M; Huang Y; Jankowska AM; Pape UJ; Tahiliani M; Bandukwala HS; An J; Lamperti ED; Koh KP; Ganetzky R; Liu XS; Aravind L; Agarwal S; Maciejewski JP; Rao A
Nature; 2010 Dec; 468(7325):839-43. PubMed ID: 21057493
[TBL] [Abstract][Full Text] [Related]
10. [Functional analysis of TET2 using a knockdown mouse model].
Shide K; Kameda T; Shimoda K
Rinsho Ketsueki; 2015 Jun; 56(6):657-65. PubMed ID: 26256876
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of TET2-mediated conversion of 5-methylcytosine to 5-hydroxymethylcytosine disturbs erythroid and granulomonocytic differentiation of human hematopoietic progenitors.
Pronier E; Almire C; Mokrani H; Vasanthakumar A; Simon A; da Costa Reis Monte Mor B; Massé A; Le Couédic JP; Pendino F; Carbonne B; Larghero J; Ravanat JL; Casadevall N; Bernard OA; Droin N; Solary E; Godley LA; Vainchenker W; Plo I; Delhommeau F
Blood; 2011 Sep; 118(9):2551-5. PubMed ID: 21734233
[TBL] [Abstract][Full Text] [Related]
12. Divergent Effects of Dnmt3a and Tet2 Mutations on Hematopoietic Progenitor Cell Fitness.
Ostrander EL; Kramer AC; Mallaney C; Celik H; Koh WK; Fairchild J; Haussler E; Zhang CRC; Challen GA
Stem Cell Reports; 2020 Apr; 14(4):551-560. PubMed ID: 32220332
[TBL] [Abstract][Full Text] [Related]
13. A zebrafish model of myelodysplastic syndrome produced through tet2 genomic editing.
Gjini E; Mansour MR; Sander JD; Moritz N; Nguyen AT; Kesarsing M; Gans E; He S; Chen S; Ko M; Kuang YY; Yang S; Zhou Y; Rodig S; Zon LI; Joung JK; Rao A; Look AT
Mol Cell Biol; 2015 Mar; 35(5):789-804. PubMed ID: 25512612
[TBL] [Abstract][Full Text] [Related]
14. Tet2 Regulates Osteoclast Differentiation by Interacting with Runx1 and Maintaining Genomic 5-Hydroxymethylcytosine (5hmC).
Chu Y; Zhao Z; Sant DW; Zhu G; Greenblatt SM; Liu L; Wang J; Cao Z; Tho JC; Chen S; Liu X; Zhang P; Maciejewski JP; Nimer S; Wang G; Yuan W; Yang FC; Xu M
Genomics Proteomics Bioinformatics; 2018 Jun; 16(3):172-186. PubMed ID: 29908294
[TBL] [Abstract][Full Text] [Related]
15. [TET2 as a gatekeeper for hematologic malignancies].
Muto H; Sakata-Yanagimoto M; Chiba S
Rinsho Ketsueki; 2015 Jun; 56(6):651-6. PubMed ID: 26256875
[TBL] [Abstract][Full Text] [Related]
16. TET proteins and 5-methylcytosine oxidation in hematological cancers.
Ko M; An J; Pastor WA; Koralov SB; Rajewsky K; Rao A
Immunol Rev; 2015 Jan; 263(1):6-21. PubMed ID: 25510268
[TBL] [Abstract][Full Text] [Related]
17. TET2 deficiency inhibits mesoderm and hematopoietic differentiation in human embryonic stem cells.
Langlois T; da Costa Reis Monte-Mor B; Lenglet G; Droin N; Marty C; Le Couédic JP; Almire C; Auger N; Mercher T; Delhommeau F; Christensen J; Helin K; Debili N; Fuks F; Bernard OA; Solary E; Vainchenker W; Plo I
Stem Cells; 2014 Aug; 32(8):2084-97. PubMed ID: 24723429
[TBL] [Abstract][Full Text] [Related]
18. TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis.
Quivoron C; Couronné L; Della Valle V; Lopez CK; Plo I; Wagner-Ballon O; Do Cruzeiro M; Delhommeau F; Arnulf B; Stern MH; Godley L; Opolon P; Tilly H; Solary E; Duffourd Y; Dessen P; Merle-Beral H; Nguyen-Khac F; Fontenay M; Vainchenker W; Bastard C; Mercher T; Bernard OA
Cancer Cell; 2011 Jul; 20(1):25-38. PubMed ID: 21723201
[TBL] [Abstract][Full Text] [Related]
19. Tet2-Mediated Clonal Hematopoiesis Accelerates Heart Failure Through a Mechanism Involving the IL-1β/NLRP3 Inflammasome.
Sano S; Oshima K; Wang Y; MacLauchlan S; Katanasaka Y; Sano M; Zuriaga MA; Yoshiyama M; Goukassian D; Cooper MA; Fuster JJ; Walsh K
J Am Coll Cardiol; 2018 Feb; 71(8):875-886. PubMed ID: 29471939
[TBL] [Abstract][Full Text] [Related]
20. The Cell Type-Specific 5hmC Landscape and Dynamics of Healthy Human Hematopoiesis and TET2-Mutant Preleukemia.
Nakauchi Y; Azizi A; Thomas D; Corces MR; Reinisch A; Sharma R; Cruz Hernandez D; Köhnke T; Karigane D; Fan A; Martinez-Krams D; Stafford M; Kaur S; Dutta R; Phan P; Ediriwickrema A; McCarthy E; Ning Y; Phillips T; Ellison CK; Guler GD; Bergamaschi A; Ku CJ; Levy S; Majeti R
Blood Cancer Discov; 2022 Jul; 3(4):346-367. PubMed ID: 35532363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]